{
    "attributes": {
        "action": "Reconsider making antiGD2 immunotherapy available as treatment for Neuroblastoma",
        "additional_details": "",
        "background": "Anti GD2 antibody treatment is proven to increase long term survival in children fighting neuroblastoma. It is par for the course in the US and Europe but has not been selected for NHS funding.",
        "closed_at": null,
        "created_at": "2018-05-04T21:01:10.348Z",
        "creator_name": null,
        "debate": null,
        "debate_outcome_at": null,
        "debate_threshold_reached_at": null,
        "government_response": null,
        "government_response_at": null,
        "moderation_threshold_reached_at": "2018-05-04T21:22:01.879Z",
        "opened_at": null,
        "rejected_at": "2018-05-10T18:58:51.359Z",
        "rejection": {
            "code": "duplicate",
            "details": "https://petition.parliament.uk/petitions/215415"
        },
        "response_threshold_reached_at": null,
        "scheduled_debate_date": null,
        "signature_count": 21,
        "state": "rejected",
        "updated_at": "2018-05-10T18:59:32.696Z"
    },
    "id": 219381,
    "links": {
        "self": "https://petition.parliament.uk/petitions/219381.json"
    },
    "type": "petition"
}